« zurück zum Suchergebnis

Molecular therapy

Titel:	Molecular therapy / American Society of Gene & Cell Therapy
Unterreihe:	Oncolytics
Körperschaft:	American Society of Gene & Cell Therapy (Herausgebendes Organ)
Veröffentlicht:	Cambridge, MA : Cell Press, 2017- London : Nature Publishing Group, 2014-2016
Erscheinungsverlauf:	Volume 1 (2014)-volume 31 (2023)
Umfang:	Online-Ressource
Format:	Elektronische Zeitschrift
Sprache:	Englisch
Schlagworte:	Zeitschrift
Frühere/Spätere Titel:	Fortgesetzt durch: . Molecular therapy. Oncology
ISSN:	2372-7705

alg: 36766539
001A    $06050:14-12-15 
001B    $06050:19-09-24 $t18:52:39.000 
001D    $06050:14-12-15 
001U    $0utf8 
001X    $00 
002@    $0Obvc 
002C    $aText $btxt $2rdacontent 
002D    $aComputermedien $bc $2rdamedia 
002E    $aOnline-Ressource $bcr $2rdacarrier 
003@    $0367665395 
003O    $01368884390 $aOCoLC 
004E/07 $0DOAJ-b32b2d155ca64ce187b2d2d659567f2b 
005A    $02372-7705 
006Z    $02842549-2 
007A    $02842549-2 $aZDB 
009Q    $S0 $uhttps://www.cell.com/molecular-therapy-family/oncology/current $xH 
009Q    $S0 $uhttps://www.ncbi.nlm.nih.gov/pmc/journals/2899/ $xH 
009Q    $S0 $uhttps://www.sciencedirect.com/journal/molecular-therapy-oncolytics $xH 
009Q    $uhttps://ezb.ur.de/?2842549-2 $xF 
010@    $aeng 
010E    $erda 
011@    $a2014 $b2023 $nDecember 2014-December 2023 
013D    $RPresse $RFortlaufendes Sammelwerk $#Periodicals $#Yearbooks $#Périodiques $#Annuaires $#Publicaciones periódicas $#journals $#Periodical $#Periodicals as Topic $#Zeitschrift $#Zeitschrift $#Periodikum $#Zeitschriften $74067488-5 $8Zeitschrift [Tsz] $9085189774 
016A    $aDg 
018@    $0u 
021A    $aMolecular therapy $hAmerican Society of Gene & Cell Therapy 
021C    $aOncolytics 
029F    $BHerausgebendes Organ $RAmerican Society of Gene Therapy $#American Society of Gene and Cell Therapy $#ASGCT $4isb $7109061814X $8American Society of Gene & Cell Therapy [Tb3] $9375759417 
031@    $aVolume 1 (2014)-volume 31 (2023) 
031N    $c12 $d1 $j2014 $k2023 
033A    $pCambridge, MA $h2017- $zs $nCell Press 
033A    $pLondon $h2014-2016 $ze $nNature Publishing Group 
034D    $aOnline-Ressource 
037A    $aGesehen am 19.09.2024 
037I    $aNamensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International $qDOAJ $2cc $uhttps://creativecommons.org/licenses/by-nc-nd/4.0/ $fCC BY-NC-ND 4.0 
037J    $aOpen Access $qDOAJ $2star $uhttp://purl.org/coar/access_right/c_abf2 $fUnrestricted online access 
039E    $aFortgesetzt durch $bs $8--Obvc--. Molecular therapy. Oncology $9518025578 
045U    $e610 

lok: 36766539 3

exp: 36766539 3 1 #EPN
201B/01 $002-05-24 $t00:27:07.508 
201U/01 $0utf8 
203@/01 $0764820311 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=UBFM $XF 

lok: 36766539 5

exp: 36766539 5 1 #EPN
201B/01 $002-05-24 $t00:27:07.511 
201U/01 $0utf8 
203@/01 $076482032X 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=FHF $XF 

lok: 36766539 8

exp: 36766539 8 1 #EPN
201B/01 $002-05-24 $t00:27:07.520 
201U/01 $0utf8 
203@/01 $0764820338 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=TUDA $XF 

lok: 36766539 10

exp: 36766539 10 1 #EPN
201B/01 $002-05-24 $t00:27:07.523 
201U/01 $0utf8 
203@/01 $0764820346 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=FHDA $XF 

lok: 36766539 11

exp: 36766539 11 1 #EPN
201B/01 $002-05-24 $t00:27:07.528 
201U/01 $0utf8 
203@/01 $0764820354 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=HLB $XF 

lok: 36766539 20

exp: 36766539 20 1 #EPN
201B/01 $002-05-24 $t00:27:07.531 
201U/01 $0utf8 
203@/01 $0764820362 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=FHGF $XF 

lok: 36766539 21

exp: 36766539 21 1 #EPN
201B/01 $002-05-24 $t00:27:07.535 
201U/01 $0utf8 
203@/01 $0764820370 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=FHFD $XF 

lok: 36766539 23

exp: 36766539 23 1 #EPN
201B/01 $002-05-24 $t00:27:07.539 
201U/01 $0utf8 
203@/01 $0764820389 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=UBKAS $XF 

lok: 36766539 24

exp: 36766539 24 1 #EPN
201B/01 $021-05-24 $t22:40:37.063 
201U/01 $0utf8 
203@/01 $0764820397 
208@/01 $a14-12-15 $bl 
209S/01 $S0 $uhttps://www.cell.com/molecular-therapy-family/oncology/current $XH 
209S/01 $S0 $uhttps://www.sciencedirect.com/journal/molecular-therapy-oncolytics $XH 
209S/01 $S0 $uhttps://www.ncbi.nlm.nih.gov/pmc/journals/2899/ $XH 

lok: 36766539 25

exp: 36766539 25 1 #EPN
201B/01 $002-05-24 $t00:27:07.569 
201U/01 $0utf8 
203@/01 $0764820400 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=UBMZ $XF 

lok: 36766539 107

exp: 36766539 107 1 #EPN
201B/01 $002-05-24 $t00:27:07.574 
201C/01 $017-04-20 
201U/01 $0utf8 
203@/01 $01101316691 
208@/01 $a17-04-20 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=MARTI $XF 

lok: 36766539 108

exp: 36766539 108 1 #EPN
201B/01 $002-05-24 $t00:27:07.577 
201C/01 $017-04-20 
201U/01 $0utf8 
203@/01 $01101316705 
208@/01 $a17-04-20 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=THB $XF 

lok: 36766539 204

exp: 36766539 204 1 #EPN
201B/01 $002-05-24 $t00:27:07.580 
201U/01 $0utf8 
203@/01 $0764820443 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=UBGIE $XF 

lok: 36766539 205

exp: 36766539 205 1 #EPN
201B/01 $002-05-24 $t00:27:07.582 
201U/01 $0utf8 
203@/01 $0764820451 
208@/01 $a14-12-15 $bl 
209S/01 $uhttps://ezb.ur.de/?2842549-2&bibid=UBMA $XF

LEADER	00000cas a2200000 c 4500
001	367665395
003	DE-603
005	20240919185239.0
007	cr\|\|\|\|\|\|\|\|\|\|\|\|
008	151214d20142023xx u\| p\|o 0 \|1eng c
016	7		\|2 DE-600 \|a 2842549-2
022			\|a 2372-7705
028	5	2	\|a DOAJ-b32b2d155ca64ce187b2d2d659567f2b
035			\|a (DE-599)ZDB2842549-2
035			\|a (OCoLC)1368884390
040			\|a DE-603 \|b ger \|c DE-603 \|d DE-603 \|e rda
041			\|a eng
084			\|a 610 \|q DE-600 \|2 sdnb
245	0	0	\|a Molecular therapy \|n [...] \|p Oncolytics \|c American Society of Gene & Cell Therapy
264		1	\|a London \|b Nature Publishing Group \|c 2014-2016
264	3	1	\|a Cambridge, MA \|b Cell Press \|c 2017-
300			\|a Online-Ressource
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
362	0		\|a Volume 1 (2014)-volume 31 (2023)
363	0	0	\|8 1.1\x \|a 1 \|j 12 \|i 2014
363	1	0	\|8 1.2\x \|i 2023
500			\|a Gesehen am 19.09.2024
655		7	\|a Zeitschrift \|2 gnd-content \|0 (DE-588)4067488-5 \|0 (DE-603)085189774
710	2		\|a American Society of Gene & Cell Therapy \|e Herausgebendes Organ \|4 isb \|0 (DE-603)375759417 \|0 (DE-588)109061814X \|2 gnd
785	0	0	\|i Fortgesetzt durch \|t Molecular therapy. Oncology \|w (DE-603)518025578 \|w (DE-600)3186967-1
856			\|u https://www.cell.com/molecular-therapy-family/oncology/current \|x Verlag \|z kostenfrei
856			\|u https://www.ncbi.nlm.nih.gov/pmc/journals/2899/ \|x Verlag \|z kostenfrei
856			\|u https://www.sciencedirect.com/journal/molecular-therapy-oncolytics \|x Verlag \|z kostenfrei
856			\|u https://ezb.ur.de/?2842549-2 \|x EZB
924	1		\|9 603 \|a (DE-603)764820311 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)76482032X \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820338 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820346 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820354 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820362 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820370 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820389 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820397 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820400 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1101316691 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1101316705 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820443 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)764820451 \|b DE-603 \|c HES \|d d

Molecular therapy

Links

Folgen Sie uns auf...